Sector Investors News and Insights

Barclays has increased the price target for Replimune Group by $4, citing reasons for the increase.

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly’s real-time, streaming news feed keeps individual…

Read More: https://thefly.com/permalinks/entry.php/id3930504/REPL-Replimune-Group-price-target-raised-by–at-Barclays-heres-why1717751486

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.